AI driven immune Leverage Sight's proprietary AI-enabled immune profiling to position offerings as enabling faster, more precise immune monitoring for biotech and pharma partners seeking scalable immune signatures and actionable insights.

Data platform Highlight the patented data platform and live cell analysis to target contract research organizations, biotechs, and academic labs needing unique immune activation metrics for drug discovery, biomarker development, and translational studies.

Scale potential Emphasize the ability to generate immune signatures at scale to prospective customers pursuing large-scale immune profiling studies, enabling parallel experimentation and accelerated timelines.

Industry relevance Position Sight as complementary to precision medicine initiatives, immuno-oncology programs, and translational research efforts, tapping into partners exploring AI-enhanced immune analytics and real-time decision making.

Strategic partnerships Target collaborations with biotech accelerators, CROs, and pharmaceutical clients that require advanced data analytics, cloud-based workflows (AWS, MySQL, Jupyter), and integrated BI tooling to streamline research pipelines.